Business
Distribution agreement with Sysmex Asia Pacific
Distribution agreement with Sysmex Asia Pacific.
About this update from Genedrive Plc
[{"type":"text","content":"\n \nRNS Number : 3708W Genedrive PLC 14 November 2017 \n\n \n14 November 2017 \nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.\n \ngenedrive plc (\"genedrive\" or the \"Company\")\ngenedrive signs distribution agreement with Sysmex Asia Pacific Pte Ltd for HCV \nAgreement extends global commercial coverage\ngenedrive plc (AIM: GDR), the near patient molecular diagnostics company, today announces that it has signed a distribution agreement with Sysmex Asia Pacific Pte Ltd, a subsidiary of Sysmex Corporation, for its CE-marked Genedrive® HCV ID Kit and Genedrive® platform in the Asia Pacific region. This is the second agreement signed with a subsidiary of Sysmex Corporation, a world leader in clinical laboratory systemization and solutions, and follows the announcement on 16th October 2017 of a distribution agreement for the EMEA region with Sysmex Europe GmbH.\nThe agreement with Sysmex Asia Pacific follows the same structure as the agreement with Sysmex Europe, with genedrive retaining responsibility for product development, quality management and manufacturing, and Sysmex Asia Pacific being responsible for sales, marketing, customer support and distribution activities across the region. Working together, the companies will focus on securing the required regulatory approvals in individual territories across Asia. genedrive anticipates some initial traction during the 2017/2018 financial year, with a further ramp up in 2018/19 when regulatory milestones are met. genedrive has retained the rights over the Indian market.\n \nDavid Budd, CEO of genedrive, commented: \"We are extremely pleased to extend our commercial reach with Sysmex Asia Pacific as our commercial partner for our Genedrive® HCV assay. This agreement provides access to another important and very relevant global region for Genedrive® encompassing countries with a high HCV burden.\" \nFrank Buescher, President and CEO of Sysmex Asia Pacific, commented: \"We are excited about this collaboration opportunity with genedrive and incorporating their HCV assay in our...